Prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 40-80 years; 2. Patients with pathologically confirmed prostate cancer requiring radical prostatectomy; 3. Patients eligible for intermediate to high risk prostate cancer (PSA >= 10ng/mL, or >= T2b stage, or Gleason score >= 7); 4. Patients who understand and voluntarily sign the written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with prostate cancer with distant metastasis; 2. Patients with severe cardiopulmonary abnormalities or other underlying diseases that prevent surgical treatment; 3. Patients with prostate cancer who have been treated with medication or radiotherapy; 4. Patients with previous transurethral resection of the prostate or pelvic surgery; 5. Patients with severe anxiety, depression, mania or other psychiatric conditions that prevent them from cooperating with treatment and follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 18F-PSMA PET/CT Inspection results;Postoperative prostate and pelvic lymph node pathology results;Postoperative Serum PSA level;Time to post-operative biochemical recurrence/tumour progression; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time of operation;Intraoperative bleeding volume;Perioperative complications; | — |
Countries
China
Contacts
Chinese PLA General Hospital